Cargando…
Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
Currently, a marked number of clinical trials on cancer treatment have revealed the success of immunomodulatory therapies based on immune checkpoint inhibitors that activate tumor-specific T cells. However, the therapeutic efficacy of cancer immunotherapies is only restricted to a small fraction of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829092/ https://www.ncbi.nlm.nih.gov/pubmed/29527212 http://dx.doi.org/10.3389/fimmu.2018.00353 |